High court order on diabetes drug patent may reduce prices 0 22.07.2021 07:56 Economictimes.indiatimes.com The cost for treating diabetes is expected to come down with the Delhi high court having dismissed an appeal by AstraZeneca, which had sought the restraining of the generic versions of a blockbuster drug. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа Другие проекты от SMI24.net Музыкальные новости Агрегатор новостей 24СМИ
